Blog
RSS FeedPosted by Michael Wonder on 27 Nov 2017
Merck invited to submit a CDF proposal for Merkel cell cancer drug
27 November 2017 - NICE has asked Merck to submit a Cancer Drugs Fund proposal for an immunotherapy called avelumab. ...
Posted by Michael Wonder on 09 Mar 2016
European scheme to develop drugs for diseases with no treatment launched
8 March 2016 - Unlike the UK’s Early Access to Medicines scheme, PRIME does not shorten the authorisation procedure. ...
Posted by Michael Wonder on 27 Oct 2015
Public consultation starts on PRIME - a new scheme to optimise development of priority medicines and facilitate patients’ access
26 October 2015 - PRIME aims to strengthen support to medicines that have the potential to benefit patients who presently have ...
Posted by Michael Wonder on 11 Sep 2015
Merck intends to submit cladribine tablets to treat multiple sclerosis for registration in Europe
11 September 2015 -Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials ...